Pentwater Capital Management’s Amedisys AMED Stock Holding History

Pentwater Capital Management’s Portfolio AMED Stock Details AMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-651,000	Closed	-$62.8M	–	97
2024 Q3	$62.8M	Hold	651,000	–	–	0.65%	29
2024 Q2	$59.8M	Hold	651,000	–	–	0.77%	30
2024 Q1	$60M	Hold	651,000	–	–	0.61%	26
2023 Q4	$61.9M	Buy	+651,000	New	+$60.8M	0.69%	32

Other funds holding AMED

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

MCI

MRP Capital Investments Alpharetta, Georgia $115M AUM 48.08% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Pentwater Capital Management's AMED Position: Q3 2025 in Review

Pentwater Capital Management sold out of Amedisys (AMED) in Q3 2025, closing a stake of 1,715,084 shares — an estimated $169M sold.

Pentwater Capital Management first reported a position in AMED in Q2 2023 and held it in 9 quarters. The position peaked at $169M in Q2 2025. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.

Pentwater Capital Management reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
Pentwater Capital Management sold 1,715,084 Amedisys shares in Q3 2025, an estimated $169M.
Pentwater Capital Management first reported a position in Amedisys in Q2 2023 and held it in 9 quarters.
Pentwater Capital Management's Amedisys position peaked at $169M in Q2 2025.
4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.

Based on Pentwater Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.